Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Excelsior Biopharma Inc (6496) Financial Statements

Excelsior Biopharma Inc Financial Overview

Excelsior Biopharma Inc's market cap is currently NT$1.13B. The company's EPS TTM is NT$-4.45; its P/E ratio is -5.88; and it has a dividend yield of 3.55%. Excelsior Biopharma Inc has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 898.26MNT$ 861.91MNT$ 771.56MNT$ 671.76MNT$ 1.34B
Gross ProfitNT$ 360.17MNT$ 382.10MNT$ 306.93MNT$ 287.17MNT$ 293.35M
Operating IncomeNT$ -174.16MNT$ -78.73MNT$ -81.13MNT$ -25.32MNT$ -1.02M
EBITDANT$ -92.90MNT$ -8.40MNT$ -29.37MNT$ 4.41MNT$ 23.16M
Net IncomeNT$ -183.17MNT$ -98.70MNT$ -91.01MNT$ -33.76MNT$ -15.65M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 185.34MNT$ 251.53MNT$ 589.92MNT$ 1.11BNT$ 1.10B
Total AssetsNT$ 1.48BNT$ 1.58BNT$ 1.58BNT$ 1.71BNT$ 1.84B
Total DebtNT$ 533.46MNT$ 438.49MNT$ 377.40MNT$ 375.83MNT$ 397.19M
Net DebtNT$ 348.12MNT$ 198.41MNT$ -212.51MNT$ -519.44MNT$ -705.57M
Total LiabilitiesNT$ 679.78MNT$ 586.89MNT$ 472.87MNT$ 507.53MNT$ 608.90M
Stockholders' EquityNT$ 804.23MNT$ 991.45MNT$ 1.10BNT$ 1.21BNT$ 1.23B
Cash Flow
Free Cash FlowNT$ -175.67MNT$ -356.95MNT$ -170.41MNT$ -2.30MNT$ 52.95M
Operating Cash FlowNT$ -138.72MNT$ -99.80MNT$ -134.75MNT$ 5.49MNT$ 55.82M
Investing Cash FlowNT$ -24.40MNT$ -307.03MNT$ 146.62MNT$ -199.24MNT$ -10.68M
Financing Cash FlowNT$ 108.38MNT$ 56.99MNT$ -317.23MNT$ -13.73MNT$ -83.04M

Currency in TWD

Excelsior Biopharma Inc Earnings and Revenue History

-800M0800M1.6B-24 %-12 %0 %12 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Excelsior Biopharma Inc Liabilities to Assets

0800M1.6B2.4B24 %32 %40 %48 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Excelsior Biopharma Inc Cash Flow

-400M-200M0200M400M600M202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Excelsior Biopharma Inc Forecast EPS vs Actual EPS

-1.3-1.2-1.1-1-0.9-0.8-0.7-0.6Q2 25Q3 25Q4 25Q1 26Q3 26Q4 26EPS EstimateBeatMiss
Earnings >